类风湿关节炎与炎症性肠病的双向关联:一项大规模前瞻性队列研究
在基于人群的大规模长期随访前瞻性队列中,基线无癌症的参与者被分为基线IBD随访新发RA(队列1)和基线RA随访新发IBD(队列2)。经多变量调整后,IBD患者新发RA风险显著升高(HR=1.44;95%CI:1.15,1.79),RA患者新发IBD风险亦升高(HR=1.65;95%CI:1.31,2.09)。作者认为需进一步研究确认并阐明生物学机制。
要点
- IBD患者新发RA风险显著升高(HR=1.44;95%CI:1.15,1.79),溃疡性结肠炎患者亦升高(HR=1.36;95%CI:1.06,1.75)。
- RA患者新发IBD风险升高(HR=1.65;95%CI:1.31,2.09),其中UC风险HR=1.60(95%CI:1.20,2.13),CD风险HR=1.65(95%CI:1.12,2.42)。
- 作者结论指出IBD与新发RA风险升高相关,反之亦然,并认为需进一步研究确认结果并阐明生物学机制。
核心结论
- IBD与新发RA风险升高相关,RA与新发IBD风险升高亦相关(原文结论:IBD is associated with an increased risk of RA, and vice versa)。
- 作者指出需进一步研究确认这些发现并阐明潜在的生物学机制。
研究设计与样本
- 基于人群的大规模长期随访前瞻性队列研究,基线无任何癌症的参与者被纳入并分为两个前瞻性队列。
- 队列1为基线IBD随访新发RA,共纳入449 662名参与者,基线时IBD患病5015例。
- 队列2为基线RA随访新发IBD(分别分析UC和CD),共纳入450 534名参与者,基线时RA患病5887例。
- 采用Cox比例风险回归模型探究RA与IBD之间的双向关系。
主要发现
- 队列1中位随访14.3年,识别新发RA 6001例(1.3%)。
- 队列2中位随访14.6年,识别新发IBD 2988例(0.7%)。
- 多变量调整后,与非IBD相比,IBD患者新发RA风险显著升高(HR=1.44;95%CI:1.15,1.79),UC患者亦升高(HR=1.36;95%CI:1.06,1.75)。
- RA患者新发IBD风险升高1.65倍(95%CI:1.31,2.09),其中UC风险升高60%(HR=1.60;95%CI:1.20,2.13),CD风险升高65%(HR=1.65;95%CI:1.12,2.42)。
- 进一步的敏感性分析和亚组分析结果相似。
关键数值与推荐
- IBD患者新发RA的HR=1.44(95%CI:1.15,1.79),对照为非IBD。
- UC患者新发RA的HR=1.36(95%CI:1.06,1.75),对照为非IBD。
- RA患者新发IBD的HR=1.65(95%CI:1.31,2.09)。
- RA患者新发UC的HR=1.60(95%CI:1.20,2.13),新发CD的HR=1.65(95%CI:1.12,2.42)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者在结论中指出需进一步研究确认这些发现并阐明潜在的生物学机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the bidirectional prospective association between inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) in a large-scale, long-term follow-up, population-based cohort. METHODS: Participants free of any cancer at baseline were included and divided into two prospective cohorts: baseline IBD and incident RA (cohort 1), and baseline RA and incident IBD (cohort 2). The primary outcome was incident RA in cohort 1 and incident IBD, including ulcerative colitis (UC) and Crohn's disease (CD), in cohort 2, separately. Cox proportional hazard regression models were used to investigate the bidirectional relationship between RA and IBD. RESULTS: Overall, 449 662 and 450 534 participants were included in cohort 1 and cohort 2, respectively, with 5015 prevalent IBD and 5887 prevalent RA cases at baseline, respectively. During a median of 14.3- and 14.6-year follow-up, 6001 (1.3%) cases of RA and 2988 (0.7%) cases of IBD were identified in cohort 1 and 2, respectively. Compared with non-IBD, IBD patients (hazard ratio [HR] = 1.44; 95% CI: 1.15, 1.79) showed a significantly higher risk of incident RA, particularly in UC patients (HR = 1.36; 95% CI: 1.06, 1.75) after multivariable adjustment. Similarly, RA patients had a 1.65-fold higher risk (95% CI: 1.31, 2.09) of incident IBD, with a 60% and 65% excess risk of developing UC (HR = 1.60; 95% CI: 1.20, 2.13) and CD (HR = 1.65; 95% CI: 1.12, 2.42), respectively. Further sensitivity analysis and subgroup analysis indicated similar results. CONCLUSION: IBD is associated with an increased risk of RA, and vice versa. Further studies are warranted to confirm the findings and elucidate the underlying biological mechanisms.
引用
- Chen Y, Zhang Q, Liu S, et al. Bidirectional association of rheumatoid arthritis and inflammatory bowel diseases: a large-scale prospective cohort study. Rheumatology (Oxford). 2025. PMID: 40511997. doi:10.1093/rheumatology/keaf337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。